Global Pharmaceutical Regulatory Affairs Summit
Informa Life Sciences’ Global Pharmaceutical Regulatory Affairs Summit, taking place on 27th – 29th October 2015 in Berlin, Germany, combines…
Read more
Central European private spending on health to exceed €21bn
Private healthcare markets in Central Europe are still young markets replete with opportunities. There is substantial demand for such services…
EMA Releases List of Medical Events for Pharmacovigilance Monitoring
The European Medicines Agency (EMA) has released a list of standardized terms describing medical events it says will be used…
Hungary spends 745 M EUR on hospital developments in Budapest
The government has allocated around 235 billion forints (EUR 754.6m) towards the first phase of hospital development and upgrades planned…
Medicinessafety monitoring : StatusandProspects
Based on the WHO definition pharmacovigilance is “scientific research related to the detection, assessment, understanding and prevention of adverse reactions…
Changes in pricing of medical products
Belarus: Decree no 228 of 21 June 2016 establishes new rules for pricing of pharmaceuticals, medical devices and medical equipment (“medical…
Sales of mid- and high-priced drugs in Russia continue to decline
Sales of mid- and high-priced drugs in Russia are steadily declining, due to the ongoing economic stagnation in the country…
Czech Pharma Industry Leaders Meet to Discuss New Legislation
Prague, 20 June 1016 – The Prague office of Baker & McKenzie recently hosted the latest in a series of…
Medical device regulation in the EU and US needs urgent reform, say experts
Patients and clinicians need greater regulatory transparency to make informed decisions about treatment. Medical devices approved first in the European…
PSUR Repository
The PSUR repository is a single, central platform for PSURs and related documents to be used by all regulatory authorities…